abstract |
The invention relates to the association of a short-acting hypnotic agent chosen from a modulator of GABA-A receptors, a benzodiazepine, phenothiazines, a melatonin derivatives, a melatonin receptor agonists and an agent Long-acting hypnotic chosen from a modulator of GABA-A receptors, a benzodiazepine, a 5HT2A receptor antagonist, a calcium ion modulator to treat sleep disorders. The invention also relates to Galenic formulations that enclose this association. |